# US 2009/0270385 A1 · Substituted arylcyclopentenes as therapeutic agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270385 A1
- Document ID: US20090270385A1
- Status: Published application
- Kind: A1
- Application number: 12/427,803
- Filed: 2009-04-22
- Published: 2009-10-29
- Earliest claimed: 2008-04-24
- Assignees: Allergan, Inc.
- Inventors: David W. Old; Vinh X. Ngo
- Web page: https://patentgrep.com/patent/US20090270385A1

## CPC

- C07C 69/736: the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
- A61P 17/14: for baldness or alopecia
- A61P 27/06: Antiglaucoma agents or miotics
- C07C 405/00: Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins {; Analogues or derivatives thereof}
- C07D 295/104: with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D 333/38: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07C 2601/08: the ring being saturated
- C07C 2601/10: the ring being unsaturated
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.

## Claims

### Claim 1

A compound of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof;
wherein Y is
A is —(CH2)6—, cis —CH2CH═CH—(CH2)3—, or —CH2C≡C—(CH2)3—, wherein 1 or 2 carbon atoms may be replaced by S or O; or A is —(CH2)m—Ar—(CH2)o— wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein 1 —CH2— may be replaced by S or O, and 1 —CH2-CH2— may be replaced by —CH═CH— or —C≡C—;
G is H or OH; and
B is aryl or heteroaryl.

### Claim 2 (depends on 1)

The compound of claim 1 wherein A has a structure selected from

### Claim 3 (depends on 2)

The compound of claim 2 wherein A is 5-(3-propyl)thiophen-2-yl.

### Claim 4 (depends on 1)

The compound of claim 1 wherein A is 6-hexyl.

### Claim 5 (depends on 1)

The compound of claim 1 wherein A is (Z)-6-hex-4-enyl.

### Claim 6 (depends on 1)

The compound of claim 1 wherein B is a substituted phenyl.

### Claim 7 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 8 (depends on 7)

The compound of claim 7 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 9 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof;
wherein a dashed line represents the presence or absence of a bond.

### Claim 10 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 11 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 12 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 13 (depends on 1)

The compound of claim 1 of the formula
or a pharmaceutically acceptable salt thereof or a prodrug thereof.

### Claim 14 (depends on 1)

A method for treating baldness comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to claim 1.
